There is a critical need for a better Zika testing method, one that can assess if a Zika positive result may be due to cross-reactivity from exposure to another flavivirus and also provides information to determine how flavivirus status affects immunity to vaccines and subsequent exposures. Ampersand Biosciences has developed a commercial multiplex serological assay on the Luminex platform, the xMAP® Flavivirus Serology Panel (xMAP® FSP), that can determine levels of IgG and IgM to 13 flavivirus antigens, along with chikungunya, in serum or plasma samples.
|Kit||IgG Wells||IgM Wells||Part Number|
|xMAP® Flavivirus Serology Panel 1-1||48||48||MP001-1|
|xMAP® Flavivirus Serology Panel 1-2||96||N/A||MP001-2|
|xMAP® Flavivirus Serology Panel 1-3||96||96||MP001-3|
*xMAP Flavivirus Serology Panel 1-1 & 1-3 Only
(Pretreat IgM only)
This product is for Research Use Only, not for use in Diagnostic procedures. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.
Manufactured by Ampersand Biosciences and distributed by Luminex Corporation.